Browse current Lyell Immunopharma openings that JobDrop found directly from the company's careers source.
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approx
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approx
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approx
Lyell Immunopharma is a clinical-stage biopharmaceutical company developing next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. As Lyell advances toward BLA submission and commercial launch, we are building an agile, effective Cell Therapy Commercial organization. The Vice
Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. Reporting to the Chief Medical Officer, the Vice President or Sr. Vice President, Head of Medical Affairs will lead the U.S. Medical Affairs function and team,
The Quality Assurance Specialist provides QA oversight for Facility, Equipment, Utility (FEU), and Computer System (CS) programs in a cell therapy manufacturing environment, with accountability for review, approval, escalation, and lifecycle compliance activities that support GMP readiness and sustained operational con
The Director, Clinical Development will serve as a key clinical contributor embedded in Lyell's small, high-impact development team. This individual contributor role is responsible for providing medical and scientific leadership across one or more clinical trials, supporting protocol development, regulatory interaction